https://www.selleckchem.com/pr....oducts/rucaparib.htm
An advantage of this strategy is the ability to administer (R)-ND-336 concurrently with an antibiotic.Both cerium oxide (CeOx) nanoparticles and mefenamic acid (MFA) are known anti-inflammatory agents with hepatoprotective properties and are therefore prescribed for one of the major diseases in the world, nonalcoholic fatty liver disease (NAFLD). To study the potential cytotoxicity and anti-inflammatory effects as well as drug retention of a potential therapeutic CeOx/MFA supramolecular complex, a well-standardized hepatic (HepG2) sph
Like
Comment
Share
